Short-term functional outcome in psychotic patients: results of the Turku early psychosis study (TEPS).
Clinical high risk of psychosis
Disorganization symptoms
Functional outcome
Negative symptoms
Premorbid adjustment
Psychotic disorders
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
02 12 2021
02 12 2021
Historique:
received:
14
04
2021
accepted:
28
09
2021
entrez:
3
12
2021
pubmed:
4
12
2021
medline:
27
1
2022
Statut:
epublish
Résumé
Functional recovery of patients with clinical and subclinical psychosis is associated with clinical, neuropsychological and developmental factors. Less is known about how these factors predict functional outcomes in the same models. We investigated functional outcomes and their predictors in patients with first-episode psychosis (FEP) or a confirmed or nonconfirmed clinical high risk of psychosis (CHR-P vs. CHR-N). Altogether, 130 patients with FEP, 60 patients with CHR-P and 47 patients with CHR-N were recruited and extensively examined at baseline (T0) and 9 (T1) and 18 (T2) months later. Global Assessment of Functioning (GAF) at T0, T1 and T2 and psychotic, depression, and anxiety symptoms at T1 and T2 were assessed. Functional outcomes were predicted using multivariate repeated ANOVA. During follow-up, the GAF score improved significantly in patients with FEP and CHR-P but not in patients with CHR-N. A single marital status, low basic education level, poor work situation, disorganization symptoms, perceptual deficits, and poor premorbid adjustment in patients with FEP, disorganization symptoms and poor premorbid adjustment in patients with CHR-P, and a low basic education level, poor work situation and general symptoms in patients with CHR-N predicted poor functional outcomes. Psychotic symptoms at T1 in patients with FEP and psychotic and depression symptoms at T1 and anxiety symptoms at T2 in patients with CHR-P were associated with poor functioning. In patients with FEP and CHR-P, poor premorbid adjustment and disorganization symptomatology are common predictors of the functional outcome, while a low education level and poor work situation predict worse functional outcomes in patients with FEP and CHR-N. Interventions aimed at improving the ability to work and study are most important in improving the functioning of patients with clinical or subclinical psychosis.
Sections du résumé
BACKGROUND
Functional recovery of patients with clinical and subclinical psychosis is associated with clinical, neuropsychological and developmental factors. Less is known about how these factors predict functional outcomes in the same models. We investigated functional outcomes and their predictors in patients with first-episode psychosis (FEP) or a confirmed or nonconfirmed clinical high risk of psychosis (CHR-P vs. CHR-N).
METHODS
Altogether, 130 patients with FEP, 60 patients with CHR-P and 47 patients with CHR-N were recruited and extensively examined at baseline (T0) and 9 (T1) and 18 (T2) months later. Global Assessment of Functioning (GAF) at T0, T1 and T2 and psychotic, depression, and anxiety symptoms at T1 and T2 were assessed. Functional outcomes were predicted using multivariate repeated ANOVA.
RESULTS
During follow-up, the GAF score improved significantly in patients with FEP and CHR-P but not in patients with CHR-N. A single marital status, low basic education level, poor work situation, disorganization symptoms, perceptual deficits, and poor premorbid adjustment in patients with FEP, disorganization symptoms and poor premorbid adjustment in patients with CHR-P, and a low basic education level, poor work situation and general symptoms in patients with CHR-N predicted poor functional outcomes. Psychotic symptoms at T1 in patients with FEP and psychotic and depression symptoms at T1 and anxiety symptoms at T2 in patients with CHR-P were associated with poor functioning.
CONCLUSIONS
In patients with FEP and CHR-P, poor premorbid adjustment and disorganization symptomatology are common predictors of the functional outcome, while a low education level and poor work situation predict worse functional outcomes in patients with FEP and CHR-N. Interventions aimed at improving the ability to work and study are most important in improving the functioning of patients with clinical or subclinical psychosis.
Identifiants
pubmed: 34856968
doi: 10.1186/s12888-021-03516-4
pii: 10.1186/s12888-021-03516-4
pmc: PMC8641211
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
602Informations de copyright
© 2021. The Author(s).
Références
J Rehabil Res Dev. 2005 Nov-Dec;42(6):829-38
pubmed: 16680620
Br J Psychiatry. 2016 Jul;209(1):14-22
pubmed: 27103678
Psychol Bull. 2013 May;139(3):548-605
pubmed: 22925137
Schizophr Bull. 2010 Sep;36(5):1001-8
pubmed: 19321629
Schizophr Bull. 2018 Feb 15;44(2):254-263
pubmed: 29036402
Schizophr Res. 2003 Dec 15;65(2-3):75-86
pubmed: 14630300
Psychol Med. 2009 Sep;39(9):1447-56
pubmed: 19187566
Schizophr Res. 2019 Apr;206:67-74
pubmed: 30558978
J Psychiatr Res. 2015 Sep;68:293-300
pubmed: 26028551
J Ment Health. 2020 Aug;29(4):376-384
pubmed: 30675805
Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31
pubmed: 17909124
Curr Psychiatry Rep. 2014 Jul;16(7):452
pubmed: 24828284
Schizophr Bull. 2018 Apr 6;44(3):584-592
pubmed: 28666366
J Affect Disord. 2016 Oct;203:101-110
pubmed: 27285723
Psychol Med. 2009 Dec;39(12):2025-42
pubmed: 19796428
Early Interv Psychiatry. 2019 Aug;13(4):935-942
pubmed: 30033690
JAMA Psychiatry. 2020 Jul 1;77(7):755-765
pubmed: 32159746
Schizophr Res Cogn. 2016 Jul 08;5:21-27
pubmed: 28740813
Aust N Z J Psychiatry. 2003 Aug;37(4):399-406
pubmed: 12873323
Schizophr Res. 2015 Dec;169(1-3):193-198
pubmed: 26585219
J Neuropsychiatry Clin Neurosci. 2011 Fall;23(4):457-60
pubmed: 22231319
Arch Gen Psychiatry. 2001 Feb;58(2):158-64
pubmed: 11177117
JAMA Psychiatry. 2020 Feb 1;77(2):190-200
pubmed: 31722018
Psychiatr Serv. 2014 Apr 1;65(4):469-75
pubmed: 24382594
Arch Gen Psychiatry. 2008 Jan;65(1):28-37
pubmed: 18180426
Br J Psychiatry. 1998 Jun;172:513-7
pubmed: 9828992
Soc Psychiatry Psychiatr Epidemiol. 2007 May;42(5):372-80
pubmed: 17492406
JAMA Psychiatry. 2013 Nov;70(11):1133-42
pubmed: 24006090
Eur Psychiatry. 2013 Oct;28(8):469-75
pubmed: 23394823
Can J Psychiatry. 2005 Dec;50(14):892-900
pubmed: 16494258
Schizophr Bull. 2013 Nov;39(6):1296-306
pubmed: 23172003
Psychiatry Res. 2013 Nov 30;210(1):8-15
pubmed: 23790604
Br J Psychiatry. 2017 Dec;211(6):350-358
pubmed: 28982659
Schizophr Res. 2017 Apr;182:120-128
pubmed: 27667369
Schizophr Res. 2003 Mar 1;60(1):21-32
pubmed: 12505135
Schizophr Res. 2014 Nov;159(2-3):267-77
pubmed: 25261041
Eur Psychiatry. 2014 Aug;29(6):371-80
pubmed: 24315804
Schizophr Res. 2015 Jun;165(1):52-9
pubmed: 25868932
Schizophr Bull. 2000;26(1):119-36
pubmed: 10755673
Eur Psychiatry. 2015 Mar;30(3):388-404
pubmed: 25749390
Schizophr Bull. 2014 Jan;40(1):120-31
pubmed: 23180756
Schizophr Res. 2009 Sep;113(2-3):189-99
pubmed: 19628375
J Nerv Ment Dis. 1962 Dec;135:534-43
pubmed: 13995749
Soc Psychiatry Psychiatr Epidemiol. 2013 Feb;48(2):303-11
pubmed: 22797132
Schizophr Res. 2012 Jul;138(2-3):192-7
pubmed: 22464922
Schizophr Res. 2011 Oct;132(1):1-7
pubmed: 21763109
Schizophr Bull. 1982;8(3):470-84
pubmed: 7134891
Br J Psychiatry Suppl. 1998;172(33):14-20
pubmed: 9764121
Arch Gen Psychiatry. 2010 Mar;67(3):241-51
pubmed: 20194824
J Abnorm Soc Psychol. 1961 Jul;63:137-46
pubmed: 14486244
Br J Psychiatry. 1983 Feb;142:145-51
pubmed: 6839067
Acta Psychiatr Scand. 1967;43(4):432-43
pubmed: 5582394
Eur Psychiatry. 2017 May;42:49-54
pubmed: 28212505
Psychiatry Res. 2017 Jan;247:55-62
pubmed: 27863320
Am J Psychiatry. 2002 May;159(5):863-5
pubmed: 11986145
Neuropsychiatr Dis Treat. 2015 Dec 17;11:3111-25
pubmed: 26719696
Schizophr Res. 1990 Oct-Dec;3(5-6):333-45
pubmed: 2282339
Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79
pubmed: 21924589
Schizophr Res. 2008 Feb;99(1-3):119-24
pubmed: 18023329
J Abnorm Soc Psychol. 1962 Oct;65:215-22
pubmed: 14003638
Schizophr Bull. 2015 Sep;41(5):1066-75
pubmed: 26272875
Nat Rev Dis Primers. 2015 Nov 12;1:15067
pubmed: 27189524
Schizophr Res. 2006 May;84(1):100-11
pubmed: 16563699
World Psychiatry. 2019 Jun;18(2):146-161
pubmed: 31059632
Psychiatry Res. 2015 Aug 30;228(3):808-15
pubmed: 26071897
JAMA Psychiatry. 2016 Feb;73(2):113-20
pubmed: 26719911
Acta Psychiatr Scand. 2012 Jan;125(1):45-53
pubmed: 21883099
Psychosom Med. 1987 Jul-Aug;49(4):331-40
pubmed: 3615762
Schizophr Bull. 1978;4(1):25-47
pubmed: 34208
Early Interv Psychiatry. 2013 Aug;7(3):300-5
pubmed: 23343384
Arch Gen Psychiatry. 2012 Mar;69(3):220-9
pubmed: 22393215
Arch Gen Psychiatry. 1967 Jun;16(6):693-8
pubmed: 6027367
Soc Psychiatry Psychiatr Epidemiol. 2001 Aug;36(8):381-90
pubmed: 11766968
JAMA Psychiatry. 2018 Nov 1;75(11):1156-1172
pubmed: 30267047
Psychol Med. 1999 May;29(3):697-701
pubmed: 10405091
Schizophr Res. 2016 Aug;175(1-3):72-78
pubmed: 27117677
Eur J Psychotraumatol. 2016 Mar 30;7:30062
pubmed: 27032511